Clinical trial Recruiting at 1 site Observational Ages 55 and up

Analyzing metabolic profiles of blood stem cells in older adults with clonal hematopoiesis

Official title: Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP): a Prospective Observational Study

Run by Imelda Hospital, Bonheiden · NCT05246813 · Data updated 2026-11-12

This study is trying to see how aging affects blood stem cells in older adults with certain genetic changes, by looking at blood and bone marrow samples taken during hip surgery.

More Aging trials

Quick facts

Study typeObservational
Ages55 Years and up
SexAll
Enrollment24 (estimated)
SponsorImelda Hospital, Bonheiden
Academic / other
Locations1 site (Bonheiden, België)
StatusRecruiting
StartedFebruary 11, 2022
Main results expectedDecember 31, 2028
Study endsDecember 31, 2030
Registry record updatedMarch 25, 2026
Trial IDNCT05246813 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 65 years and older who are scheduled for hip arthroplasty surgery.

Probably not a fit

Patients with known hematological conditions such as myelodysplasia, leukemia, or cancer will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study involves collecting blood and bone marrow samples from patients aged 65 and older who are undergoing hip arthroplasty surgery. The samples will be analyzed for metabolic profiling and to identify mutations associated with clonal hematopoiesis of indeterminate potential (CHIP). Researchers will utilize advanced techniques such as single-cell transcriptomics and mutation-specific genotyping to compare gene expression profiles of normal and mutant hematopoietic stem cells, focusing on metabolic pathways. The goal is to better understand the relationship between aging, metabolic changes, and clonal hematopoiesis.

Why it matters

Potential benefit: If successful, this study could provide insights into the metabolic changes associated with clonal hematopoiesis, potentially leading to improved management of related conditions in older adults.

How similar studies have gone: While the specific approach of this study may be novel, similar studies have shown promise in understanding the implications of clonal hematopoiesis in aging populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 65 years and older

Exclusion Criteria:

* known haematological condition (myelodysplasia, leukemia, cancer)
* inability to provide written informed consent

Where it's running

  • Imelda Hospital
    Bonheiden, België, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.